摘要
OBJECTIVE@#To explore the relationship between high altitude polycythemia (HAPC) and peptic ulcer bleeding, in order to provide the evidence for the clinical diagnosis and treatment of peptic ulcer disease in Tibet of China.@*METHODS@#A retrospective case-control study was conducted. Patients who hospitalized in the Department of Gastroenterology with the diagnosis of peptic ulcer bleeding from January 1, 2015 to April 30, 2021 in Tibet Autonomous Region People's Hospital were enrolled in the case group, and patients who hospitalized in the Department of Urology without tumor and without the history of peptic ulcer and gastrointestinal bleeding during the same period were selected as the control group. In the study, 1 ∶ 1 case matching was conducted between the two groups according to the gender, age (±2 years), ethnic group (Tibetan, Han), and the residence altitude level (grouped by < 4 000 m or ≥4 000 m), and 393 cases were included in the case group and the control group respectively. All the patients had lived in Tibet with the altitude >2 500 m for more than 1 year, and with age ≥ 18 years. The risk factors of peptic ulcer bleeding (place of residence, smoking, alcohol, the use of NSAIDs/anticoagulants, and combined with chronic diseases, such as HAPC, hypertension, diabetes mellitus, heart disease, hyperlipidemia, cerebrovascular disease, chronic lung disease, joint disease) were analyzed and compared between the two groups.@*RESULTS@#There were 28 (7.1%) patients with HAPC in the case group, and 5 (1.3%) in the control group. The incidence of HAPC in the case group was significantly higher than those in the control group, P < 0.001, and the OR value was 5.953. Multivariate Logistic regression analysis showed that HAPC (OR=5.270, 95%CI: 1.806-15.380), living in cities and towns (OR=2.369, 95%CI: 1.559-3.602), alcohol (OR=3.238, 95%CI: 1.973-5.317) and the use of NSAIDs/anticoagulants (OR=20.584, 95%CI: 2.639-160.545) were the independent risk factors for peptic ulcer bleeding in Tibet. After adjusting for the possible confounding factors, such as living in cities and towns, alcohol, and the use of NSAIDs/anticoagulants, HAPC was associated with an increased risk of peptic ulcer bleeding in Tibet, and the OR value was 5.270.@*CONCLUSION@#HAPC was associated with a significantly increased risk of peptic ulcer bleeding in Tibet. Patients with HAPC and peptic ulcer should be diagnosed and treated actively, in order to avoid gastrointestinal bleeding and other serious complications.
Subject(s)
Adolescent , Humans , Altitude , Case-Control Studies , Peptic Ulcer/epidemiology , Polycythemia/epidemiology , Retrospective Studies , Risk Factors摘要
Resumen Antecedentes: El corazón pulmonar crónico (CPC) muestra un incremento en habitantes que viven en grandes altitudes. Objetivo: Investigar la frecuencia de arritmias cardíacas y factores de riesgo para su desarrollo. Métodos: Estudio descriptivo y transversal; se revisó el registro de pacientes internados del Departamento de Cardiología del Instituto Nacional de Tórax, La Paz, Bolivia, entre enero de 2017 y junio de 2018; se incorporó a todos los individuos con diagnóstico de CPC, definido por criterios clínicos, electrocardiográficos y ecocardiográficos; se incluyó a 162 pacientes que cumplieron los criterios en el análisis; se utilizaron la t de Student y ANOVA. Resultados: Arritmias: fibrilación auricular (FA), 125 (75%); aleteo auricular (AA), 17 (10.5%); taquicardia auricular (TA), 17 (10.5%); extrasístoles, 3 (1.9%). Según el análisis univariado, los factores relacionados con el desarrollo de arritmias fueron: eritrocitosis: FA, RR: 1.33, otras arritmias (RR: 1.67), p = 0.0001; hipertensión arterial pulmonar: FA, RR: 3.10, otras arritmias (RR: 3.21), p = 0.0001; dilatación de aurícula derecha (AD): FA, RR: 1.92, otras arritmias (RR: 2.13), p = 0.0001; obesidad: FA, RR: 3.47, p = 0.001, otras arritmias (RR: 3.70), p = 0.001; hipertensión arterial sistémica: FA, RR: 3.10, p = 0.001, otras arritmias (RR: 3.21), p = 0.001. Según el análisis multivariado: eritrocitosis (RR: 2.2), dilatación de AD (RR: 1.2), p = 0.0001. Conclusiones: Se encontró FA con mayor frecuencia en los pacientes con CPC; los factores de riesgo con mayor significancia estadística para su presentación fueron la eritrocitosis y la dilatación de la AD.
Abstract Background: Chronic cor pulmonale (CPC), with increased presentation in high-altitude inhabitants. Objectives: Investigating the frequency of cardiac arrhythmias, and risk factors for its development. Methods: Descriptive, cross-sectional study, the inpatient registry of the Department of Cardiology of the National Institute of Torax, La Paz-Bolivia, from January 2017 to June 2018 was reviewed, all were incorporated with the diagnosis of CPC, defined by clinical criteria, electrocardiographic and echocardiographic, 162 patients who met the criteria were taken, the student's t-test and ANOVA were used for the analysis. Results: Arrhythmias: atrial fibrillation (AF) 125 (75%), atrial flutter (AA) 17 (10.5%), atrial tachycardia (AT) 17 (10.5%), extrasystoles 3 (1.9%). Univariate analysis of factors related to the development of arrhythmias: erythrocytosis: FA, RR: 1.33, other arrhythmias RR: 1.67, p = 0.0001, pulmonary arterial hypertension: FA, RR: 3.10, other arrhythmias RR: 3.21, p = 0.0001, right atrial dilation (AD): FA, RR: 1.92, other arrhythmias RR: 2.13, p = 0.0001, obesity: FA, RR: 3.47, p = 0.001, other arrhythmias RR: 3.70, p = 0.001, systemic arterial hypertension: FA: RR: 3.10, p = 0.001, other arrhythmias RR: 3.21, p = 0.001. Multivariate analysis: erythrocytosis (RR: 2.2), AD dilation (RR: 1.2), p = 0.0001. Conclusions: AF was found more frequently in patients with CPC, the risk factors with the greatest statistical significance for presentation were: erythrocytosis and AD dilation.
Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Arrhythmias, Cardiac/epidemiology , Pulmonary Heart Disease/epidemiology , Altitude , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/physiopathology , Polycythemia/epidemiology , Bolivia/epidemiology , Registries , Chronic Disease , Cross-Sectional Studies , Risk Factors摘要
El objetivo del trabajo fue determinar la prevalencia y el impacto de la eritrocitosis excesiva (EE) y mal de montaña crónico (MMC) en mujeres, y factores asociados en el desarrollo de estas alteraciones, principalmente la edad e índice de masa corporal (IMC). Los resultados mostraron una prevalencia de EE y MMC, de 19,72% y 25,35%, respectivamente. La edad promedio es de 39,79 ± 10,87; el hematocrito promedio fue 51,95 ± 6,85; la saturación de oxígeno fue 79,88 ± 5,24 y el IMC promedio de la participantes es 28,08 ± 3,87. La prevalencia de EE en el sexo femenino es mayor en las mujeres posmenopáusicas, en comparación a las premenopáusicas. Por otro lado, se determinó que un mayor índice de masa corporal se asocia fuertemente a menores valores de saturación de oxígeno. Entonces, así el incremento de la edad y del índice de masa corporal, favorecen el presencia de eritrocitosis excesiva más marcada condicionando un desarrollo de mal de montaña crónico de mayor severidad.
The aim of the work was to determine the prevalence and impact of excessive erytrochytes (EE) and chronic mountain sickness (MMC) in women, and related factors of the development of these alterations, mainly age and body max index (IMC). Results displayed incidence of EE and MMC, by 19.72% and 25.35%, respectively. The average age was 39.79 ± 10.87; the average hematocrit was 51.95 ± 6.85; the oxygen saturation was 79.88 ± 5.24 and the average IMC of the participants was 28.08 ± 3.87. The prevalence of EE on females is greater in postmenopausal women, in comparison to pre menopausals. On the other hand, it was determined that a greater body mass index is strongly associated to lesser oxygen saturation values. Hence, the increase of age and body max index, favor the most marked excesive erytrochytes presence conditioning the most serious acute mountain sickness.
Subject(s)
Humans , Female , Adult , Polycythemia/epidemiology , Altitude Sickness/epidemiology , Peru , Menopause , Body Mass Index , Prevalence , Cross-Sectional Studies , Prospective Studies , Risk Factors , Age Factors , Altitude , Oxygen Saturation , Hematocrit摘要
A variety of methods for testosterone replacement therapy (TRT) exist, and the major potential risks of TRT have been well established. The risk of developing polycythemia secondary to exogenous testosterone (T) has been reported to range from 0.4% to 40%. Implantable T pellets have been used since 1972, and secondary polycythemia has been reported to be as low as 0.4% with this administration modality. However, our experience has suggested a higher rate. We conducted an institutional review board-approved, single-institution, retrospective chart review (2009-2013) to determine the rate of secondary polycythemia in 228 men treated with subcutaneously implanted testosterone pellets. Kaplan-Meyer failure curves were used to estimate time until the development of polycythemia (hematocrit >50%). The mean number of pellets administered was 12 (range: 6-16). The mean follow-up was 566 days. The median time to development of polycythemia whereby 50% of patients developed polycythemia was 50 months. The estimated rate of polycythemia at 6 months was 10.4%, 12 months was 17.3%, and 24 months was 30.2%. We concluded that the incidence of secondary polycythemia while on T pellet therapy may be higher than previously established.
Subject(s)
Adult , Aged , Humans , Male , Middle Aged , Androgens/adverse effects , Drug Implants , Hematocrit , Hormone Replacement Therapy/methods , Hypogonadism/drug therapy , Kaplan-Meier Estimate , Polycythemia/epidemiology , Retrospective Studies , Testosterone/adverse effects摘要
High altitude polycythemia is one of the altitude illnesses. Sana'a region is located at high altitude which reaches 3600 meters above the sea level. To determine the hematological and clinical features of polycythemic patients residing in Sana'a region and to clarify the effect of high altitude in causing polycythemia. Hematological, clinical and demographic data were obtained from 30 polycythemic patients [26 males, 4 females, aged 26 to 85 years residing Sana'a region and referred to the National Centre of Public Health Laboratories in Sana'a city for the first time venesection. All studied samples showed high hemoglobin levels [mean 18.85 g/dl for both sexes], normal platelet counts [228 and 267 x10[9]/L for males and females, respectively], normal white cell counts in 96.7% of the cases [means 6.01 to 5.98 x10[9]/L. Their clinical features showed predominance of headache, ruddy cyanosis, dyspnea and night sweating by 86.7%, 76.7%, 70% and 60%, respectively, Hypertension, joint pain, renal disease, peptic ulcer were less commonly mentioned by 36.7%, 20%, 13.3%, and 10%, respectively. Hemorrhage, pruritus, splenomegaly, heart disease and liver disease were observed by only 6.67% each. Findings suggest that secondary polycythemia is predominant among polycythemic patients due to the high altitude of Sana'a region. Findings needs to be confirmed by studying a larger sample and extended to investigate the erythropoietin level and JAK2V617F mutation for accurate diagnosis
Subject(s)
Humans , Male , Female , Polycythemia/blood , Polycythemia/epidemiology , Epidemiologic Studies摘要
Objetivos. Establecer la frecuencia de anemia y eritrocitosis en gestantes de diferentes regiones del Perú y la asociación con los resultados adversos perinatales utilizando los datos del Sistema de Información Perinatal (SIP) del Ministerio de Salud (MINSA). Materiales y métodos. Se obtuvieron datos de 379 816 partos de 43 centros asistenciales del Ministerio de Salud entre los años 2000 y 2010. Se determinó la frecuencia de anemia y eritrocitosis en cada región geográfica así como de los resultados adversos perinatales. Resultados. La frecuencia de anemia leve fue mayor en la costa (25,8 por ciento) y en la selva baja (26,2 por ciento). La frecuencia de anemia moderada/severa es más alta en la selva baja (2,6 por ciento) seguido de la costa (1,0 por ciento). En la sierra, las frecuencia más alta de anemia moderada/severa se observa en la sierra sur (0,6 por ciento). La mayor frecuencia de eritrocitosis (Hb>14,5 g/dL) fue encontrada en la sierra centro (23,7 por ciento), seguido de 11,9 por ciento en la sierra sur y 9,5 por ciento en la sierra norte. La anemia severa y la eritrocitosis estuvieron relacionadas con los resultados adversos perinatales. Conclusiones. Hay diferencias por región geográfica en la frecuencia de anemia. En la sierra central se encontró mayor frecuencia de eritrocitosis con respecto a la sierra sur. Tanto la anemia severa como la eritrocitosis aumentan los resultados adversos perinatales.
Objectives. To evaluate hemoglobin (Hb) levels in pregnant women from different geographical regions from Peru; to establish anemia and erythrocytocis rates and to establish the role of Hb on adverse perinatal outcomes using the Perinatal Information System (PIS) database of Peruvian Ministry of Health. Materials and methods. Data were obtained from 379,816 births of 43 maternity care units between 2000 and 2010. Anemia and erythrocytocis rates were determined in each geographical region as well as rates of adverse perinatal outcomes. To analyze data the STATA program (versión 10.0,Texas, USA) was used. The results were considered significant at p<0.01. Results. Mild anemia rate was higher in the coast (25.8 percent) and low forest (26.2 percent). Moderate/severe anemia rate in low forest was 2.6 percent and at the coast was 1.0 percent. In the highland, the highest rate of moderate/severe anemia was in the southern highlands (0.6 percent). The highest rate of erythrocytocis was found in the central highland (23.7 percent), 11.9 percent in the southern highland and 9.5 percent in the north highland. Severe anemia and erythrocytocis were associated with adverse perinatal outcomes. Conclusions. There are differences by Peruvian geographical region in anemia rates. In the central highlands were found the highest rates of erythrocytocis due to hypoxia effect in the high altitudes; however in the southern highlands, erythrocytocis was lower. Severe anemia and erythrocytosis were associated with increased adverse perinatal outcomes.
Subject(s)
Female , Humans , Infant, Newborn , Pregnancy , Anemia/blood , Hemoglobins/analysis , Polycythemia/blood , Pregnancy Complications, Hematologic/blood , Anemia/epidemiology , Peru/epidemiology , Polycythemia/epidemiology , Pregnancy Outcome摘要
Descreve-se um caso de eritrocitose absoluta (hematócrito: 74 por cento, hemoglobina: 24,2g/dl) em um cão com tumor venéreo transmissível cutâneo. A concentração de hemoglobina e o hematócrito retornaram ao valor normal após o tratamento com vincristina. A remissão da eritrocitose após o tratamento é sugestiva de uma associação entre o tumor e a alteração hematológica.
This report describes a case of absolute erythrocytosis (hematocrit: 74 percent, hemoglobin: 24.2g/dl) in a dog with transmissible cutaneous venereal tumor. Hemoglobin and hematocrit returned to normal range after the treatment with vincristine. The remission of the erythrocytosis after treatment suggests a relationship between the neoplastic lesions and the hematological abnormality.
Subject(s)
Animals , Dogs , Polycythemia/epidemiology , Venereal Tumors, Veterinary/diagnosis摘要
461 consecutive inborn babies, delivered during the period September 1993-March 1994 were subjected to a microhematocrit assessment at 6 hours of age to determine the incidence of polycythemia. 47 babies (inborn and out born), admitted to the neonatal unit with confirmed polycythemia were studied for clinical and laboratory abnormalities. These 47 babies were then randomly assigned to receive partial exchange transfusion with either normal saline or fresh plasma. The incidence of polycythemia was 27 of 461 (5.8%). 23 of 27 (85.1%) were term babies and 15 of 27 (55.5%) were small for gestational age. 14 of 27 (51.1%) babies had mothers who had pregnancy induced hypertension. Feeding problems (16/47) and lethargy (25/47) were the commonest symptoms (34% and 51% respectively). 25 of 47 (51%) babies had hypoglycemia and 5 of 47 (10.6%) had hypocalcemia. Thrombocytopenia was seen in 13/47 (27.65%) of cases. 24 babies received normal saline and 23 received fresh plasma for partial exchange transfusion. The immediate post-exchange fall in hematocrit was significant in both groups and this was well sustained over the following 48 hours. However, improvement in clinical and laboratory parameters was more remarkable with fresh plasma. Polycythemia appears to be a real clinical entity in neonates in India and babies with known risk factors should be actively screened for this condition. Once diagnosis is established special attempts should be made to rule out hypoglycemia. For treatment of polycythemia fresh plasma is preferable for partial exchange transfusion but normal saline appears to be an adequate substitute.
Subject(s)
Exchange Transfusion, Whole Blood , Female , Hematocrit , Humans , Incidence , India/epidemiology , Infant, Newborn , Polycythemia/epidemiology , Pregnancy , Risk Factors , Statistics, Nonparametric摘要
Polycythemia (venous PCV greater than 65%) in neonates is not an infrequent occurrence. Over the last 2 years out of approximately 1500 admissions to the Neonatal Unit, polycythemia was detected in 46 babies (3.06%). Seventeen (36%) of these babies were preterm and 29 (63%) were term. Approximately one third were small for dates while 2 babies (4%) were large for dates. Four of them had been born to mothers with gestational diabetes and 7 were twin deliveries. Severe perinatal asphyxia (5 minute Apgar score less than or equal to 5) was present in 12 cases (26%). Symptoms suggestive of polycythemia included lethargy in 15%, refusal to feed in 13%, respiratory distress in 10%, vomiting in 8% and abdominal distension in 6%. Associated hypoglycemia was seen in 5 cases (10.8%) while twelve babies (26%) had significant jaundice (bilirubin greater than or equal to 12 mg/dl). Twenty eight babies (60.8%) were given a partial plasma exchange transfusion through the umbilical route. There was 6.5% mortality in these 46 babies with polycythemia. Blood letting through a peripheral vein along with a plasma infusion may be a safer alternative to partial plasma exchange transfusion through umbilical route in babies with polycythemia.
Subject(s)
Bloodletting , Hospitals, University , Humans , India/epidemiology , Infant, Newborn , Plasma Exchange , Polycythemia/epidemiology , Retrospective Studies摘要
Se revisaron 300 volemias de casos remitidos al Instituto de Hematología e Inmunología por presentar cifras de hematocrito por encima de lo normal. Las volemias se agruparon de acuerdo con el resultado de volumen plasmático, en 154 policitemias absolutas y 116 relativas. Del total de volemias, 30 fueron normales. Hubo un predominio del sexo masculino que se mantuvo al agrupar a los pacientes según el resultado de la volemia. En cuanto a edad, se observó que la policitemia absoluta, fue más frecuente en la sexta década de la vida, mientras que la relativa lo fue en la tercera. Se apreció que el aumento del volumen globular se acompañaba de un incremento del hematocrito, sobre todo con los valores más altos de este último. Esto también sucedió con la policitemia relativa, pero de manera inversa, donde la mayoría se agrupó en las cifras más bajas de hematocrito. Se concluye que la frecuencia de policitemia absoluta y relativa según el sexo, edad y hematocrito, es similar a lo señalado por otros autores
Subject(s)
Adolescent , Adult , Middle Aged , Humans , Male , Female , Polycythemia/epidemiology , Blood Volume , Hematocrit摘要
Se estudiaron 200 recién nacidos en un periodo de cuatro meses en un hospital del Estado de México, con el objeto de conocer la frecuencia de policitemia neonatal (PN), antecedentes maternos y manifestaciones clínicas. Se determinaron hematócrito central y periférico, glucosa, plaquetas y leucocitos en las primeras 24 horas de vida, haciendo el diagnóstico de PN con un valor del hematócrito de 65% o mayor, en muestra de vena antecubital. La frecuencia encontrada fue del 12% en las primeras 12 horas de vida y de 6.5% a las 24 horas. El grupo de mayor riesgo fue el de recién nacidos (RN) pequeños para su edad gestacional que la presentaron en 35%, seguidos de los hijos de madre toxémica con 32%. Se documentó hipoglucemia y trombocitopenia en las dos terceras partes de los pacientes y las manifestaciones clínicas que predominaron fueron rubicandez y acrocianosis en 92% de los casos. Se concluye que la frecuencia de PN en el hospital estudiado fue superior a la informada en la literatura y se le relaciona con las horas de vida al momento de la toma de la muestra